 | • レポートコード：MRC2-11QY12573 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は大うつ病性障害（MDD）のグローバル市場について調査・分析したレポートです。種類別（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別大うつ病性障害（MDD）の競争状況、市場シェア ・世界の大うつ病性障害（MDD）市場：種類別市場規模 2015年-2020年（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他） ・世界の大うつ病性障害（MDD）市場：種類別市場規模予測 2021年-2026年（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他） ・世界の大うつ病性障害（MDD）市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の大うつ病性障害（MDD）市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の大うつ病性障害（MDD）市場分析：米国、カナダ ・ヨーロッパの大うつ病性障害（MDD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの大うつ病性障害（MDD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の大うつ病性障害（MDD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの大うつ病性障害（MDD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、GlaxoSmithKline、Merck、AstraZeneca、Eli Lily、Johnson & Johnson、Forest Laboratories、Sanofi-Aventis、H. Lundbeck、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Major Depressive Disorder (MDD) is a common mental illness characterized by persistent low mood that interferes with the person’s ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression. The common symptoms of this mental disorder are insomnia, loss of interest, recurrent thoughts of death, feelings of worthlessness and reduced ability to think. The rising prevalence of major depression has led to a sharp increase in the patient volume suffering from depression. Currently, many treatments and therapies are available for major depression but the market still holds a large scope of growth opportunities with high unmet needs of the market.
The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.
Market Analysis and Insights: Global Major Depressive Disorder (MDD) Market
The global Major Depressive Disorder (MDD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Major Depressive Disorder (MDD) Scope and Market Size
Major Depressive Disorder (MDD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Major Depressive Disorder (MDD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
GlaxoSmithKline
Merck
AstraZeneca
Eli Lily
Johnson & Johnson
Forest Laboratories
Sanofi-Aventis
H. Lundbeck
Bristol-Myers Squibb
Market segment by Type, the product can be split into
Antidepressant Drugs
SSRIs
SNRIs
Benzodiazepines
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Major Depressive Disorder (MDD) Revenue
1.4 Market by Type
1.4.1 Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antidepressant Drugs
1.4.3 SSRIs
1.4.4 SNRIs
1.4.5 Benzodiazepines
1.4.6 Others
1.5 Market by Application
1.5.1 Global Major Depressive Disorder (MDD) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Major Depressive Disorder (MDD) Market Perspective (2015-2026)
2.2 Global Major Depressive Disorder (MDD) Growth Trends by Regions
2.2.1 Major Depressive Disorder (MDD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Major Depressive Disorder (MDD) Historic Market Share by Regions (2015-2020)
2.2.3 Major Depressive Disorder (MDD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Major Depressive Disorder (MDD) Market Growth Strategy
2.3.6 Primary Interviews with Key Major Depressive Disorder (MDD) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Major Depressive Disorder (MDD) Players by Market Size
3.1.1 Global Top Major Depressive Disorder (MDD) Players by Revenue (2015-2020)
3.1.2 Global Major Depressive Disorder (MDD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Major Depressive Disorder (MDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Major Depressive Disorder (MDD) Market Concentration Ratio
3.2.1 Global Major Depressive Disorder (MDD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder (MDD) Revenue in 2019
3.3 Major Depressive Disorder (MDD) Key Players Head office and Area Served
3.4 Key Players Major Depressive Disorder (MDD) Product Solution and Service
3.5 Date of Enter into Major Depressive Disorder (MDD) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Major Depressive Disorder (MDD) Historic Market Size by Type (2015-2020)
4.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
5.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Major Depressive Disorder (MDD) Market Size (2015-2020)
6.2 Major Depressive Disorder (MDD) Key Players in North America (2019-2020)
6.3 North America Major Depressive Disorder (MDD) Market Size by Type (2015-2020)
6.4 North America Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Major Depressive Disorder (MDD) Market Size (2015-2020)
7.2 Major Depressive Disorder (MDD) Key Players in Europe (2019-2020)
7.3 Europe Major Depressive Disorder (MDD) Market Size by Type (2015-2020)
7.4 Europe Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
8 China
8.1 China Major Depressive Disorder (MDD) Market Size (2015-2020)
8.2 Major Depressive Disorder (MDD) Key Players in China (2019-2020)
8.3 China Major Depressive Disorder (MDD) Market Size by Type (2015-2020)
8.4 China Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Major Depressive Disorder (MDD) Market Size (2015-2020)
9.2 Major Depressive Disorder (MDD) Key Players in Japan (2019-2020)
9.3 Japan Major Depressive Disorder (MDD) Market Size by Type (2015-2020)
9.4 Japan Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Major Depressive Disorder (MDD) Market Size (2015-2020)
10.2 Major Depressive Disorder (MDD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Major Depressive Disorder (MDD) Market Size by Type (2015-2020)
10.4 Southeast Asia Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
11 India
11.1 India Major Depressive Disorder (MDD) Market Size (2015-2020)
11.2 Major Depressive Disorder (MDD) Key Players in India (2019-2020)
11.3 India Major Depressive Disorder (MDD) Market Size by Type (2015-2020)
11.4 India Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Major Depressive Disorder (MDD) Market Size (2015-2020)
12.2 Major Depressive Disorder (MDD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Major Depressive Disorder (MDD) Market Size by Type (2015-2020)
12.4 Central & South America Major Depressive Disorder (MDD) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Major Depressive Disorder (MDD) Introduction
13.1.4 Pfizer Revenue in Major Depressive Disorder (MDD) Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Major Depressive Disorder (MDD) Introduction
13.2.4 GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Major Depressive Disorder (MDD) Introduction
13.3.4 Merck Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.3.5 Merck Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Major Depressive Disorder (MDD) Introduction
13.4.4 AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Eli Lily
13.5.1 Eli Lily Company Details
13.5.2 Eli Lily Business Overview
13.5.3 Eli Lily Major Depressive Disorder (MDD) Introduction
13.5.4 Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.5.5 Eli Lily Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Major Depressive Disorder (MDD) Introduction
13.6.4 Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Forest Laboratories
13.7.1 Forest Laboratories Company Details
13.7.2 Forest Laboratories Business Overview
13.7.3 Forest Laboratories Major Depressive Disorder (MDD) Introduction
13.7.4 Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.7.5 Forest Laboratories Recent Development
13.8 Sanofi-Aventis
13.8.1 Sanofi-Aventis Company Details
13.8.2 Sanofi-Aventis Business Overview
13.8.3 Sanofi-Aventis Major Depressive Disorder (MDD) Introduction
13.8.4 Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.8.5 Sanofi-Aventis Recent Development
13.9 H. Lundbeck
13.9.1 H. Lundbeck Company Details
13.9.2 H. Lundbeck Business Overview
13.9.3 H. Lundbeck Major Depressive Disorder (MDD) Introduction
13.9.4 H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.9.5 H. Lundbeck Recent Development
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Details
13.10.2 Bristol-Myers Squibb Business Overview
13.10.3 Bristol-Myers Squibb Major Depressive Disorder (MDD) Introduction
13.10.4 Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2015-2020)
13.10.5 Bristol-Myers Squibb Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Major Depressive Disorder (MDD) Key Market Segments
Table 2. Key Players Covered: Ranking by Major Depressive Disorder (MDD) Revenue
Table 3. Ranking of Global Top Major Depressive Disorder (MDD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antidepressant Drugs
Table 6. Key Players of SSRIs
Table 7. Key Players of SNRIs
Table 8. Key Players of Benzodiazepines
Table 9. Key Players of Others
Table 10. Global Major Depressive Disorder (MDD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Major Depressive Disorder (MDD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Major Depressive Disorder (MDD) Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Major Depressive Disorder (MDD) Market Share by Regions (2015-2020)
Table 14. Global Major Depressive Disorder (MDD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Major Depressive Disorder (MDD) Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Major Depressive Disorder (MDD) Market Growth Strategy
Table 20. Main Points Interviewed from Key Major Depressive Disorder (MDD) Players
Table 21. Global Major Depressive Disorder (MDD) Revenue by Players (2015-2020) (Million US$)
Table 22. Global Major Depressive Disorder (MDD) Market Share by Players (2015-2020)
Table 23. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder (MDD) as of 2019)
Table 24. Global Major Depressive Disorder (MDD) by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Major Depressive Disorder (MDD) Product Solution and Service
Table 27. Date of Enter into Major Depressive Disorder (MDD) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 30. Global Major Depressive Disorder (MDD) Market Size Share by Type (2015-2020)
Table 31. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2021-2026)
Table 32. Global Major Depressive Disorder (MDD) Market Size Share by Application (2015-2020)
Table 33. Global Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 34. Global Major Depressive Disorder (MDD) Market Size Share by Application (2021-2026)
Table 35. North America Key Players Major Depressive Disorder (MDD) Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Major Depressive Disorder (MDD) Market Share (2019-2020)
Table 37. North America Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 38. North America Major Depressive Disorder (MDD) Market Share by Type (2015-2020)
Table 39. North America Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 40. North America Major Depressive Disorder (MDD) Market Share by Application (2015-2020)
Table 41. Europe Key Players Major Depressive Disorder (MDD) Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Major Depressive Disorder (MDD) Market Share (2019-2020)
Table 43. Europe Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Major Depressive Disorder (MDD) Market Share by Type (2015-2020)
Table 45. Europe Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Major Depressive Disorder (MDD) Market Share by Application (2015-2020)
Table 47. China Key Players Major Depressive Disorder (MDD) Revenue (2019-2020) (Million US$)
Table 48. China Key Players Major Depressive Disorder (MDD) Market Share (2019-2020)
Table 49. China Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 50. China Major Depressive Disorder (MDD) Market Share by Type (2015-2020)
Table 51. China Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 52. China Major Depressive Disorder (MDD) Market Share by Application (2015-2020)
Table 53. Japan Key Players Major Depressive Disorder (MDD) Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Major Depressive Disorder (MDD) Market Share (2019-2020)
Table 55. Japan Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Major Depressive Disorder (MDD) Market Share by Type (2015-2020)
Table 57. Japan Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Major Depressive Disorder (MDD) Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Major Depressive Disorder (MDD) Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Major Depressive Disorder (MDD) Market Share (2019-2020)
Table 61. Southeast Asia Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Major Depressive Disorder (MDD) Market Share by Type (2015-2020)
Table 63. Southeast Asia Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Major Depressive Disorder (MDD) Market Share by Application (2015-2020)
Table 65. India Key Players Major Depressive Disorder (MDD) Revenue (2019-2020) (Million US$)
Table 66. India Key Players Major Depressive Disorder (MDD) Market Share (2019-2020)
Table 67. India Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 68. India Major Depressive Disorder (MDD) Market Share by Type (2015-2020)
Table 69. India Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 70. India Major Depressive Disorder (MDD) Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Major Depressive Disorder (MDD) Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Major Depressive Disorder (MDD) Market Share (2019-2020)
Table 73. Central & South America Major Depressive Disorder (MDD) Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Major Depressive Disorder (MDD) Market Share by Type (2015-2020)
Table 75. Central & South America Major Depressive Disorder (MDD) Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Major Depressive Disorder (MDD) Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Product
Table 90. Merck Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 91. Merck Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Product
Table 95. AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 96. AstraZeneca Recent Development
Table 97. Eli Lily Company Details
Table 98. Eli Lily Business Overview
Table 99. Eli Lily Product
Table 100. Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 101. Eli Lily Recent Development
Table 102. Johnson & Johnson Company Details
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Product
Table 105. Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 106. Johnson & Johnson Recent Development
Table 107. Forest Laboratories Company Details
Table 108. Forest Laboratories Business Overview
Table 109. Forest Laboratories Product
Table 110. Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 111. Forest Laboratories Recent Development
Table 112. Sanofi-Aventis Business Overview
Table 113. Sanofi-Aventis Product
Table 114. Sanofi-Aventis Company Details
Table 115. Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 116. Sanofi-Aventis Recent Development
Table 117. H. Lundbeck Company Details
Table 118. H. Lundbeck Business Overview
Table 119. H. Lundbeck Product
Table 120. H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 121. H. Lundbeck Recent Development
Table 122. Bristol-Myers Squibb Company Details
Table 123. Bristol-Myers Squibb Business Overview
Table 124. Bristol-Myers Squibb Product
Table 125. Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2015-2020) (Million US$)
Table 126. Bristol-Myers Squibb Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Major Depressive Disorder (MDD) Market Share by Type: 2020 VS 2026
Figure 2. Antidepressant Drugs Features
Figure 3. SSRIs Features
Figure 4. SNRIs Features
Figure 5. Benzodiazepines Features
Figure 6. Others Features
Figure 7. Global Major Depressive Disorder (MDD) Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Major Depressive Disorder (MDD) Report Years Considered
Figure 12. Global Major Depressive Disorder (MDD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Major Depressive Disorder (MDD) Market Share by Regions: 2020 VS 2026
Figure 14. Global Major Depressive Disorder (MDD) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Major Depressive Disorder (MDD) Market Share by Players in 2019
Figure 17. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder (MDD) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Major Depressive Disorder (MDD) Revenue in 2019
Figure 19. North America Major Depressive Disorder (MDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Major Depressive Disorder (MDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Major Depressive Disorder (MDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Major Depressive Disorder (MDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Major Depressive Disorder (MDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Major Depressive Disorder (MDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Major Depressive Disorder (MDD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
うつ病性障害の世界市場（～2026年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…- 慢性うつ病性人格障害治療の世界市場（～2026年） Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of …
- 脂質異常症治療の世界市場（～2026年） Lipid disorder means the people high blood levels of low-density lipoprotein (LDL) cholesterol, fats called triglycerides,. Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Phar…
- 色素沈着障害治療の世界市場（～2026年） Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color. Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are availabl…
- ENT疾患治療の世界市場（～2026年） ENT is a medical abbreviation for ears, nose and throat. Major factor contributing to growth of the global ENT disorder treatment market includes increasing pollution. Market Analysis and Insights: Global ENT Disorder Treatment Market The global ENT Disorder Treatment market size is projected to rea…